UBA5 and lung carcinoma: Meanwhile, one of the UBA5 inhibitors derived from adenosine 5′sulfamate (ADS) was demonstrated to reduce the proliferation of lung cancer cells, highlighting the possible implications of the UBA5 inhibitor for cancer therapy [82].